Healthcare >> CEO Interviews >> May 22, 2001
EDWARD L. JACOBS was appointed Chief Operating Officer of SuperGen,
Inc., in January 2004, following service as Chief Business and Financial
Officer from October 2001, and as Executive Vice President, Commercial
Operations of SuperGen from 1999 to 2001. Most recently Mr. Jacobs
served as President and Chief Executive Officer of ETEX, a Cambridge,
Massachusetts-based biomaterials and drug delivery company. Prior to
joining SuperGen Mr. Jacobs served as Senior Vice President, Commercial
Operations at Sequus Pharmaceuticals, Inc., between 1997 and 1999.
Between 1995 and 1997, Mr. Jacobs served as President and Chief
Executive Officer of Trilex Pharmaceuticals Inc., now Titan
Pharmaceuticals. Prior to his association with Trilex, Mr. Jacobs served
in a variety of senior management positions with pharmaceutical
companies, including Chief Executive at Transplant Therapeutics Inc.,
Vice President and General Manager of Syncor International Inc., Vice
President at NeoRX Corporation, Business Director of Pharmacia Labs,
Inc.) and Johnson & Johnson (McNeil). Mr. Jacobs received a BA in
Political Science/Journalism from California State University at
Northridge. Profile
Mr. Jacobs: Etex is over 10 years old. It actually was incorporated in
1989, based on calcium phosphate chemistry developed by
Dr.
